CD4 and AIDS: Accordingly, the WHO and Joint United Nation program on HIV/AIDS (UNAIDS) have recommended CPT for HIV/AIDS patients in Africa with symptomatic HIV diseases (WHO clinical stage 3 or 4) and individuals who have a CD4 count of less than or equal to 350 cells/mm3 (WHO, 2014).